![](https://www.aptyspharma.com/app/uploads/2024/07/Photo-500x500.jpg)
![bubbles](https://www.aptyspharma.com/app/themes/aptys/public/images/bulle.png?id=b34ebab69ceddf766f15)
DISCOVER OUR NEW OFFER: SOLUPREC®
To meet the demands of preclinical studies requiring increasing doses of active ingredients (pharmacology and toxicology), we have developed SOLUPREC®
Read more![](https://www.aptyspharma.com/app/uploads/2024/02/ENG-Arrivee-de-Nicolas-Tokhadze-500x500.png)
![](https://www.aptyspharma.com/app/uploads/2024/02/Bio-Europe-500x500.jpg)
![bubbles](https://www.aptyspharma.com/app/themes/aptys/public/images/bulle.png?id=b34ebab69ceddf766f15)
APTYS will attend to Bio Europe Spring in Barcelona
BIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one …
Read more![](https://www.aptyspharma.com/app/uploads/2024/02/Losan-2024-500x500.png)
![bubbles](https://www.aptyspharma.com/app/themes/aptys/public/images/bulle.png?id=b34ebab69ceddf766f15)
5th Scientific drug delivery conference
📢 François Boutignon, Aptys pharma CEO is honored to chair the upcoming conference
Read more![](https://www.aptyspharma.com/app/uploads/2024/01/Magali-Linkedin--500x500.png)
![bubbles](https://www.aptyspharma.com/app/themes/aptys/public/images/bulle.png?id=b34ebab69ceddf766f15)
Aptys welcomes its new Administrative Head
We are delighted to announce the arrival of Magali Nagorzanski as Administrative Head at APTYS.
Read more